Correction to: Dermatol Ther (Heidelb) (2024) 14:697–712 https://doi.org/10.1007/s13555-024-01119-x


  1. 1.

    In this article the affiliation details for Author Frasson Nicolas were incorrectly given as ‘Clinique Du Dr Ster, 9 Avenue Dr Jean Ster, 34240 Nîmes, France’ but should have been ‘2 Avenue du Docteur Jean Ster, 34240 Lamalou Les Bains, France’.

  2. 2.

    In this article the wrong figure appeared as Fig. 2; the figure should have appeared as shown below (Fig. 2).

    Fig. 2
    figure 2

    Effectiveness of the ADE-G2-based cream on objective dermatologic clinical signs and overall product effectiveness. a Changes in mean total severity score (scale from 0 to 12) and percentage differences in this score between baseline and follow-up in the whole study population (all types) and in the three subgroups according to the type of skin impairment. The mean score significantly decreased between baseline and follow-up in all groups. **p < 0.0001 (paired Wilcoxon test). b Overall product effectiveness at follow-up in the whole study population (all types) and in the three subgroups according to the type of skin impairment. The cumulated percentage of subjects who rated the study product as “very effective” or “effective” is indicated for each group

    Full size image
  3. 3.

    In Table 2 of this article, full header line with the 4 main subgroups to be repeated in the continued part of the table (not just the subheadings) (Table 2).

    Table 2 Severity scores and relative changes of dermatologic clinical signs and symptoms at baseline, immediately after product use and at follow up, in all subjects and in subject subgroups according to the type of skin impairment
    Full size table
  4. 4.

    Throughout the text, the trade name of the product to be corrected to “Cicalfate+” or “C+-Restore” by removing spaces between the letters and the sign “+”.